Dolutegravir AUC decreased 25%; Cmin decreased 37%
Potentially reduced dolutegravir effectiveness
Do not coadminister etravirine with dolutegravir unless atazanavir / ritonavir, darunavir / ritonavir, or lopinavir / ritonavir are also part of the regimen. When using this combo and there is known or clinically suspected INSTI resistance, increase dolutegravir dosage to 50 mg BID.

